A transgenic rabbit model for human hypertrophic cardiomyopathy. - Wikidata - wikimedia - TriplyDB

A transgenic rabbit model for human hypertrophic cardiomyopathy.

A transgenic rabbit model for human hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33903354

about

Generation of knockout rabbits using transcription activator-like effector nucleases Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Small and large animal models in cardiac contraction research: advantages and disadvantages The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.The molecular genetic basis for hypertrophic cardiomyopathy.Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy Hypertrophic cardiomyopathy: from genetics to treatment Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy.Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.Cardiac hypertrophy and failure: lessons learned from genetically engineered mice.DCM-related tropomyosin mutants E40K/E54K over-inhibit the actomyosin interaction and lead to a decrease in the number of cycling cross-bridges.Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.Molecular biology of heart disease.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy Hypertrophic cardiomyopathy: from gene defect to clinical disease.Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy.Transgenic rabbit models for studying human cardiovascular diseases.Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014)Genomics in cardiovascular disease.A novel, minimally invasive, segmental myocardial infarction with a clear healed infarct borderzone in rabbits Designing heart performance by gene transfer.Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway.Animal models of arrhythmogenic cardiomyopathy.In vivo models of cardiac diseases: application to drug development and screening.Hypertrophic cardiomyopathy: how do mutations lead to disease?Modeling human disease phenotype in model organisms: "It's only a model!".Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

P2860

Q22001128-B89FCC61-0092-4F15-B754-0E71CEBA5AB2 Q26853133-0B07BD48-C446-4CBA-8AC1-C5FC0F53AC38 Q27021919-C3085270-9CEA-4F33-B709-4C52804995F1 Q27712437-6464B750-56C3-4BB5-8EEB-7C465B051CA9 Q28344111-19B1BFA4-3088-42E4-BF79-F1A33AEEBFDF Q28658055-40BCDA10-BA51-4DA0-A6B9-ADE81C2068EC Q33305204-BF80B19D-F411-43B2-8D7E-15A2B78AE4F3 Q33919182-D46B3D76-0150-44C6-9F87-E8EB71E0B478 Q33939892-345CD3EE-6D10-4280-9A9F-6AF0699CBD2C Q33947464-539A737A-B975-4343-839E-44433B3E5C2A Q33978845-5DE4609B-9A5C-454F-A7DC-419C1F8AD964 Q33992358-535905BD-A3C3-4C1F-A43C-02E7AB0B38A1 Q34008230-CD58D3D3-E550-4F1E-84FA-E9B22E2CE338 Q34012874-5DC654B7-6C78-4994-8BDD-8C03EFDA31E8 Q34021080-E8E298C8-001A-41A4-9353-CB23C4E1DB28 Q34225704-4203A049-280B-4217-A600-84912F78EE76 Q34418993-8B482B40-4AD4-4203-9130-BE9CFE66DA83 Q34450885-2E550917-E0E9-4CF4-AC8F-6AFB6639D8DF Q34474908-B75CC902-C113-4C1D-9268-6329780F2E5A Q34790975-45D4D5BC-2BFE-400D-969D-EA1ED98C3010 Q34863040-70075F46-FE9B-45B1-9E5A-76D05DF7EE73 Q34999606-E1F9A8AF-942E-4E1B-A1AB-AC83778BD31C Q35087752-5E5FAC5C-8D10-476A-BF46-2D078C03DD33 Q35165627-F3CA178A-215C-4681-9ACF-25B1144A7A4A Q36481289-59CB6983-A1B2-4992-8BF8-96E1DDBA86C7 Q36631036-CAA86105-F7FC-4594-B6A9-C2B77E39FB03 Q36761852-69B88BE9-E41F-49E0-9FF0-5534669ACCE5 Q36781777-A4246166-C295-4836-A28A-E7BDC82DA015 Q36931805-8ABF94FC-B9F3-41BD-8C77-87B3D2DB3524 Q37174602-D8ADC4F9-659B-4CDA-AD4E-F569941CE6D7 Q37299072-8DD0587C-7903-4873-8CE0-90083FBE0148 Q37394759-E214FBDC-567A-404E-90B4-1145B541A27F Q37401938-16FB0B07-9F82-47FA-8AFD-5B5A33A41DDD Q37413082-9BD953CE-B632-4F81-B612-BB2860074CCE Q37590787-E17A8ECA-A072-46AD-8679-F7440740BAFF Q37628322-FD77B6A7-1D85-4491-9371-9ED89BDB69B2 Q38028652-8DC926A6-501B-4307-9EA8-A99029BF5CE7 Q38203157-C0F7F565-39F3-412A-872F-D8293D4C32E5 Q38256754-F10A34A3-77F4-4F2F-9577-393113F3BC80 Q39038606-65007C45-2823-42DB-ACA4-84186D161ED8

P2860

A transgenic rabbit model for human hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33903354

description

1999 nî lūn-bûn

@nan

1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@ast

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@en

type

label

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@ast

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@en

prefLabel

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@ast

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@en

P1433

Q33903354-2513F291-8D89-4EA1-9C7C-DA2297C8C9A1

P1476

Q33903354-90FF5D68-F643-43D7-84BF-1CF8B6623AF0

P2093

Q33903354-0981B936-18CC-4BAA-9488-A16D0F45ACFC

Q33903354-1849743D-09A6-433F-952A-444C1F4969EC

Q33903354-1B1EDE61-E19F-4E6B-AA28-F886EEC5D3C0

Q33903354-36B7E71B-26BF-4184-8E0D-E840D4046ED7

Q33903354-455BD751-CA26-4C9B-A9EB-7741666DEC4A

Q33903354-87989A7E-2A1F-42F5-80BB-A6B5757954DC

Q33903354-937270BF-10DD-4E00-8610-E63D1F7AA356

Q33903354-DFC4E341-0E68-4785-A0C6-94E2F053F965

Q33903354-E23E1C6F-87BC-48E4-B4F8-F1C85A2FB4F4

Q33903354-FE97B578-01F1-4B09-B165-BF6642A5E882

P2860

Q33903354-03A0ACDE-A1E1-443F-AB89-08AE64685F96

Q33903354-082CBB18-98AB-4237-AD6C-FF74DC224666

Q33903354-08B2EFDA-4865-434B-9154-0991CAAA0D0B

Q33903354-0CD1C847-0DC1-4207-9859-E1CC58D7FC7D

Q33903354-0E8F65A1-8F30-459F-BF34-00B27D0190E9

Q33903354-147917E4-04BC-43FA-B1E7-736299E70912

Q33903354-1B03E4A6-5071-463B-A71D-9BB8F2FCCE77

Q33903354-23DE9633-052A-41CA-AA16-DD9895DC2C02

Q33903354-26CD0887-7425-4AA8-86BA-FBD04E39E7E3

Q33903354-291CA64C-7283-425D-91E7-EA6C78EC5B85

P304

Q33903354-31E2D52F-54E0-4AAA-91E2-43F55C57568C

P31

Q33903354-697BD6F9-B86F-434A-90E8-CA9F0A5731D9

P356

Q33903354-83DCE647-7613-4B93-9CAA-F883E9D8D717

P407

Q33903354-39C32A26-9847-4068-9C72-D952D3746A4D

P433

Q33903354-4D0C673A-DC1F-4381-866F-37AF44801D7E

P478

Q33903354-541E56D5-FB02-4172-B1BB-E32FB070B29A

P577

Q33903354-A39B6EA6-06CB-49F9-9E58-772B324397BE

P5875

Q33903354-B742CFAE-FE2B-42FD-90DE-2F6878B16112

P698

Q33903354-79934B6E-BE7A-49B9-BB01-1AA9B6178653

P932

Q33903354-F4173C4A-787C-43F0-9479-F7DAEA4B3CD3

P356

P1433

Journal of Clinical Investigation

P1476

A transgenic rabbit model for human hypertrophic cardiomyopathy.

@en

P2093

A J Marian

http://www.w3.org/2001/XMLSchema#string

D S Lim

http://www.w3.org/2001/XMLSchema#string

F DeMayo

http://www.w3.org/2001/XMLSchema#string

K Youker

http://www.w3.org/2001/XMLSchema#string

M McCluggage

http://www.w3.org/2001/XMLSchema#string

M Quinones

http://www.w3.org/2001/XMLSchema#string

Q T Yu

http://www.w3.org/2001/XMLSchema#string

R Brugada

http://www.w3.org/2001/XMLSchema#string

R Roberts

http://www.w3.org/2001/XMLSchema#string

Y Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Myosin heavy chain gene expression in human heart failure

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility

In vivo analysis of the murine beta-myosin heavy chain gene promoter

A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy

A mouse model of familial hypertrophic cardiomyopathy

Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.

Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies.

P304

1683-1692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI7956

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51352911

http://www.w3.org/2001/XMLSchema#string

P698

10606622

http://www.w3.org/2001/XMLSchema#string

P932

409884

http://www.w3.org/2001/XMLSchema#string